Dr. Reddy's Laboratories
RDY
#1699
Rank
โ‚ฌ10.19 B
Marketcap
12,19ย โ‚ฌ
Share price
0.35%
Change (1 day)
-10.28%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ1.73 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are โ‚ฌ1.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31โ‚ฌ1.68 B41.74%
2024-03-31โ‚ฌ1.18 B16.77%
2023-03-31โ‚ฌ1.01 B-16.35%
2022-03-31โ‚ฌ1.21 B13.06%
2021-03-31โ‚ฌ1.07 B15.74%
2020-03-31โ‚ฌ0.93 B-14.96%
2019-03-31โ‚ฌ1.09 B-11.56%
2018-03-31โ‚ฌ1.23 B-10.43%
2017-03-31โ‚ฌ1.38 B31.23%
2016-03-31โ‚ฌ1.05 B-15.66%
2015-03-31โ‚ฌ1.24 B29.79%
2014-03-31โ‚ฌ0.96 B-3.97%
2013-03-31โ‚ฌ1.00 B9.43%
2012-03-31โ‚ฌ0.91 B17.43%
2011-03-31โ‚ฌ0.77 B26.11%
2010-03-31โ‚ฌ0.61 B-1%
2009-03-31โ‚ฌ0.62 B3.15%
2008-03-31โ‚ฌ0.60 B-21.62%
2007-03-31โ‚ฌ0.77 B-11.09%
2006-03-31โ‚ฌ0.86 B484.51%
2005-03-31โ‚ฌ0.14 B42.39%
2004-03-31โ‚ฌ0.10 B26.39%
2003-03-31โ‚ฌ82.49 M0.25%
2002-03-31โ‚ฌ82.28 M-49.08%
2001-03-31โ‚ฌ0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ99.31 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ52.63 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ53.71 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ56.71 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France